{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:50:16Z","timestamp":1790769016785,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T00:00:00Z","timestamp":1416009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12035-014-8974-4","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T20:43:32Z","timestamp":1415997812000},"page":"1850-1861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Inhibition of Excessive Monoamine Oxidase A\/B Activity Protects Against Stress-induced Neuronal Death in Huntington Disease"],"prefix":"10.1007","volume":"52","author":[{"given":"Jolene","family":"Ooi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Pouladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,15]]},"reference":[{"key":"8974_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/ana.410420213","volume":"42","author":"SJ Augood","year":"1997","unstructured":"Augood SJ, Faull RL, Emson PC (1997) Dopamine D1 and D2 receptor gene expression in the striatum in Huntington\u2019s disease. Ann Neurol 42:215\u2013221. doi: 10.1002\/ana.410420213","journal-title":"Ann Neurol"},{"key":"8974_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ (2011) Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83\u201398. doi: 10.1016\/S1474-4422(10)70245-3","journal-title":"Lancet Neurol"},{"key":"8974_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/ana.410220318","volume":"22","author":"SJ Kish","year":"1987","unstructured":"Kish SJ, Shannak K, Hornykiewicz O (1987) Elevated serotonin and reduced dopamine in subregionally divided Huntington\u2019s disease striatum. Ann Neurol 22:386\u2013389. doi: 10.1002\/ana.410220318","journal-title":"Ann Neurol"},{"key":"8974_CR4","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","volume":"354","author":"JH Cha","year":"1999","unstructured":"Cha JH, Frey AS, Alsdorf SA et al (1999) Altered neurotransmitter receptor expression in transgenic mouse models of Huntington\u2019s disease. Philos Trans R Soc Lond B Biol Sci 354:981\u2013989","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"8974_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.neuro.22.1.197","volume":"22","author":"JC Shih","year":"1999","unstructured":"Shih JC, Chen K, Ridd MJ (1999) Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22:197\u2013217. doi: 10.1146\/annurev.neuro.22.1.197","journal-title":"Annu Rev Neurosci"},{"key":"8974_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fnins.2013.00114","volume":"7","author":"JY Chen","year":"2013","unstructured":"Chen JY, Wang EA, Cepeda C, Levine MS (2013) Dopamine imbalance in Huntington\u2019s disease: a mechanism for the lack of behavioral flexibility. Front Neurosci 7:114. doi: 10.3389\/fnins.2013.00114","journal-title":"Front Neurosci"},{"key":"8974_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2014.10.004","author":"T Renoir","year":"2014","unstructured":"Renoir T, Argyropoulos A, Chevarin C et al (2014) Sexually dimorphic dopaminergic dysfunction in a transgenic mouse model of Huntington\u2019s disease. Pharmacol Biochem Behav. doi: 10.1016\/j.pbb.2014.10.004","journal-title":"Pharmacol Biochem Behav"},{"key":"8974_CR8","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1046\/j.1471-4159.1999.721773.x","volume":"72","author":"GP Reynolds","year":"1999","unstructured":"Reynolds GP, Dalton CF, Tillery CL et al (1999) Brain neurotransmitter deficits in mice transgenic for the Huntington\u2019s disease mutation. J Neurochem 72:1773\u20131776","journal-title":"J Neurochem"},{"key":"8974_CR9","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.1073\/pnas.120166397","volume":"97","author":"JA Bibb","year":"2000","unstructured":"Bibb JA, Yan Z, Svenningsson P et al (2000) Severe deficiencies in dopamine signaling in presymptomatic Huntington\u2019s disease mice. Proc Natl Acad Sci U S A 97:6809\u20136814. doi: 10.1073\/pnas.120166397","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8974_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fnsys.2011.00061","volume":"5","author":"JW Callahan","year":"2011","unstructured":"Callahan JW, Abercrombie ED (2011) In vivo dopamine efflux is decreased in striatum of both fragment (R6\/2) and full-length (YAC128) transgenic mouse models of Huntington\u2019s disease. Front Syst Neurosci 5:61. doi: 10.3389\/fnsys.2011.00061","journal-title":"Front Syst Neurosci"},{"key":"8974_CR11","doi-asserted-by":"publisher","first-page":"e31024","DOI":"10.1371\/journal.pone.0031024","volume":"7","author":"JL Madison","year":"2012","unstructured":"Madison JL, Wegrzynowicz M, Aschner M, Bowman AB (2012) Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism. PLoS One 7:e31024. doi: 10.1371\/journal.pone.0031024","journal-title":"PLoS One"},{"key":"8974_CR12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF00500765","volume":"322","author":"AM O\u2019Carroll","year":"1983","unstructured":"O\u2019Carroll AM, Fowler CJ, Phillips JP et al (1983) The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions. Naunyn Schmiedebergs Arch Pharmacol 322:198\u2013202","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"8974_CR13","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","volume":"119","author":"A Antonini","year":"1996","unstructured":"Antonini A, Leenders KL, Spiegel R et al (1996) Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington\u2019s disease. Brain 119(6):2085\u20132095","journal-title":"Brain"},{"issue":"12","key":"8974_CR14","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","volume":"122","author":"TC Andrews","year":"1999","unstructured":"Andrews TC, Weeks RA, Turjanski N et al (1999) Huntington\u2019s disease progression. PET and clinical observations. Brain 122(12):2353\u20132363","journal-title":"Brain"},{"key":"8974_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1468-1331.2008.02390.x","volume":"16","author":"JCH Oostrom van","year":"2009","unstructured":"van Oostrom JCH, Dekker M, Willemsen ATM et al (2009) Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington\u2019s disease. Eur J Neurol 16:226\u2013231. doi: 10.1111\/j.1468-1331.2008.02390.x","journal-title":"Eur J Neurol"},{"key":"8974_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/B978-0-12-386467-3.00002-9","volume":"100","author":"M Bortolato","year":"2011","unstructured":"Bortolato M, Shih JC (2011) Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol 100:13\u201342. doi: 10.1016\/B978-0-12-386467-3.00002-9","journal-title":"Int Rev Neurobiol"},{"key":"8974_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrn1883","volume":"7","author":"MBH Youdim","year":"2006","unstructured":"Youdim MBH, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7:295\u2013309. doi: 10.1038\/nrn1883","journal-title":"Nat Rev Neurosci"},{"key":"8974_CR18","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel F, Rigamonti D, Hilditch-Maguire P et al (2000) Dominant phenotypes produced by the HD mutation in STHdh (Q111) striatal cells. Hum Mol Genet 9:2799\u20132809","journal-title":"Hum Mol Genet"},{"key":"8974_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1124\/mol.110.067439","volume":"79","author":"K Chen","year":"2011","unstructured":"Chen K, Ou X-M, Wu JB, Shih JC (2011) Transcription factor E2F-associated phosphoprotein (EAPP), RAM2\/CDCA7L\/JPO2 (R1), and simian virus 40 promoter factor 1 (Sp1) cooperatively regulate glucocorticoid activation of monoamine oxidase B. Mol Pharmacol 79:308\u2013317. doi: 10.1124\/mol.110.067439","journal-title":"Mol Pharmacol"},{"key":"8974_CR20","doi-asserted-by":"publisher","first-page":"16723","DOI":"10.1074\/jbc.M901779200","volume":"284","author":"JB Wu","year":"2009","unstructured":"Wu JB, Chen K, Ou X-M, Shih JC (2009) Retinoic acid activates monoamine oxidase B promoter in human neuronal cells. J Biol Chem 284:16723\u201316735. doi: 10.1074\/jbc.M901779200","journal-title":"J Biol Chem"},{"key":"8974_CR21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1124\/mol.59.4.852","volume":"59","author":"WK Wong","year":"2001","unstructured":"Wong WK, Chen K, Shih JC (2001) Regulation of human monoamine oxidase B gene by Sp1 and Sp3. Mol Pharmacol 59:852\u2013859","journal-title":"Mol Pharmacol"},{"key":"8974_CR22","doi-asserted-by":"publisher","first-page":"10923","DOI":"10.1073\/pnas.0601515103","volume":"103","author":"X-M Ou","year":"2006","unstructured":"Ou X-M, Chen K, Shih JC (2006) Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proc Natl Acad Sci U S A 103:10923\u201310928. doi: 10.1073\/pnas.0601515103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8974_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","volume":"11","author":"HD iPSC Consortium","year":"2012","unstructured":"HD iPSC Consortium (2012) Induced pluripotent stem cells from patients with Huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11:264\u2013278. doi: 10.1016\/j.stem.2012.04.027","journal-title":"Cell Stem Cell"},{"key":"8974_CR24","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1073\/pnas.1014041108","volume":"108","author":"W Li","year":"2011","unstructured":"Li W, Sun W, Zhang Y et al (2011) Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors. PNAS 108:8299\u20138304. doi: 10.1073\/pnas.1014041108","journal-title":"PNAS"},{"key":"8974_CR25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1385-299X(00)00022-2","volume":"5","author":"E Magnani","year":"2000","unstructured":"Magnani E, Bettini E (2000) Resazurin detection of energy metabolism changes in serum-starved PC12 cells and of neuroprotective agent effect. Brain Res Brain Res Protoc 5:266\u2013272","journal-title":"Brain Res Brain Res Protoc"},{"key":"8974_CR26","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.1074\/jbc.273.21.13313","volume":"273","author":"HP Gerber","year":"1998","unstructured":"Gerber HP, Dixit V, Ferrara N (1998) Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273:13313\u201313316","journal-title":"J Biol Chem"},{"key":"8974_CR27","doi-asserted-by":"crossref","first-page":"19532","DOI":"10.1074\/jbc.274.28.19532","volume":"274","author":"H Sugiyama","year":"1999","unstructured":"Sugiyama H, Savill JS, Kitamura M et al (1999) Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappaB in primary glomerular mesangial cells. J Biol Chem 274:19532\u201319537","journal-title":"J Biol Chem"},{"key":"8974_CR28","first-page":"265","volume":"35","author":"A Veral","year":"1997","unstructured":"Veral A, Alper G, Mente\u015f G, Ers\u00f6z B (1997) Age and sex related alterations in serum and platelet monoamine oxidase. Eur J Clin Chem Clin Biochem 35:265\u2013268","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"8974_CR29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00702-003-0103-x","volume":"111","author":"M Markianos","year":"2004","unstructured":"Markianos M, Panas M, Kalfakis N, Vassilopoulos D (2004) Platelet monoamine oxidase activity in subjects tested for Huntington\u2019s disease gene mutation. J Neural Trans (Vienna, Austria : 1996) 111:475\u2013483. doi: 10.1007\/s00702-003-0103-x","journal-title":"J Neural Trans (Vienna, Austria : 1996)"},{"key":"8974_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/toxsci\/kft199","volume":"136","author":"M Ribeiro","year":"2013","unstructured":"Ribeiro M, Silva AC, Rodrigues J et al (2013) Oxidizing effects of exogenous stressors in Huntington\u2019s disease knock-in striatal cells\u2014protective effect of cystamine and creatine. Toxicol Sci 136:487\u2013499. doi: 10.1093\/toxsci\/kft199","journal-title":"Toxicol Sci"},{"key":"8974_CR31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","volume":"12","author":"S Gines","year":"2003","unstructured":"Gines S, Seong I-S, Fossale E et al (2003) Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington\u2019s disease knock-in mice. Hum Mol Genet 12:497\u2013508","journal-title":"Hum Mol Genet"},{"key":"8974_CR32","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","volume":"14","author":"I-S Seong","year":"2005","unstructured":"Seong I-S, Ivanova E, Lee J-M et al (2005) HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum Mol Genet 14:2871\u20132880. doi: 10.1093\/hmg\/ddi319","journal-title":"Hum Mol Genet"},{"key":"8974_CR33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/jnnp.41.9.809","volume":"41","author":"J Mann","year":"1978","unstructured":"Mann J, Chiu E (1978) Platelet monoamine oxidase activity in Huntington\u2019s chorea. J Neurol Neurosurg Psychiatr 41:809\u2013812","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"8974_CR34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archpsyc.1980.01780160095011","volume":"37","author":"K Belendiuk","year":"1980","unstructured":"Belendiuk K, Belendiuk GW, Freedman DX (1980) Blood monoamine metabolism in Huntington\u2019s disease. Arch Gen Psychiatry 37:325\u2013332","journal-title":"Arch Gen Psychiatry"},{"key":"8974_CR35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1440-1681.1987.tb01511.x","volume":"14","author":"TR Norman","year":"1987","unstructured":"Norman TR, Chiu E, French MA (1987) Platelet monoamine oxidase activity in patients with Huntington\u2019s disease. Clin Exp Pharm Phys 14:547\u2013550","journal-title":"Clin Exp Pharm Phys"},{"key":"8974_CR36","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1126\/science.6449080","volume":"210","author":"JJ Mann","year":"1980","unstructured":"Mann JJ, Stanley M, Gershon S, Rossor M (1980) Mental symptoms in Huntington\u2019s disease and a possible primary aminergic neuron lesion. Science 210:1369\u20131371","journal-title":"Science"},{"key":"8974_CR37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01249088","volume":"65","author":"JJ Mann","year":"1986","unstructured":"Mann JJ, Kaplan RD, Bird ED (1986) Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington\u2019s disease compared to schizophrenics and controls. J Neural Trans (Vienna, Austria : 1996) 65:277\u2013283","journal-title":"J Neural Trans (Vienna, Austria : 1996)"},{"key":"8974_CR38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.brainres.2010.11.020","volume":"1370","author":"G Richards","year":"2011","unstructured":"Richards G, Messer J, Waldvogel HJ et al (2011) Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington\u2019s disease revealed by quantitative enzyme radioautography. Brain Res 1370:204\u2013214. doi: 10.1016\/j.brainres.2010.11.020","journal-title":"Brain Res"},{"key":"8974_CR39","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/ng.2732","volume":"45","author":"RP Mason","year":"2013","unstructured":"Mason RP, Casu M, Butler N et al (2013) Glutathione peroxidase activity is neuroprotective in models of Huntington\u2019s disease. Nat Genet 45:1249\u20131254. doi: 10.1038\/ng.2732","journal-title":"Nat Genet"},{"key":"8974_CR40","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1096\/fj.13-235481","volume":"28","author":"JC Fitzgerald","year":"2014","unstructured":"Fitzgerald JC, Ugun-Klusek A, Allen G et al (2014) Monoamine oxidase-A knockdown in human neuroblastoma cells reveals protection against mitochondrial toxins. FASEB J 28:218\u2013229. doi: 10.1096\/fj.13-235481","journal-title":"FASEB J"},{"key":"8974_CR41","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","volume":"22","author":"S-H Li","year":"2002","unstructured":"Li S-H, Cheng AL, Zhou H et al (2002) Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 22:1277\u20131287","journal-title":"Mol Cell Biol"},{"key":"8974_CR42","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1126\/science.1072613","volume":"296","author":"AW Dunah","year":"2002","unstructured":"Dunah AW, Jeong H, Griffin A et al (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington\u2019s disease. Science 296:2238\u20132243. doi: 10.1126\/science.1072613","journal-title":"Science"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-014-8974-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8974-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8974-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-014-8974-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T11:29:47Z","timestamp":1566041387000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-014-8974-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,15]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["8974"],"URL":"https:\/\/doi.org\/10.1007\/s12035-014-8974-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,15]]}}}